Request Appointment
1400 S Orange AveOrlando, FL 32806
Overview of Dr. Thomas
Dr. Sajeve Thomas is an oncologist in Orlando, FL and is affiliated with Orlando Health Orlando Regional Medical Center. He received his medical degree from University of Florida College of Medicine and has been in practice 12 years. He is one of 68 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology. He has more than 10 publications and over 500 citings.
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 2008 - 2011
University of South Florida MorsaniResidency, Internal Medicine, 2005 - 2008- University of Florida College of MedicineClass of 2005
Certifications & Licensure
WV State Medical License 2025 - 2027
FL State Medical License 2007 - 2026
MT State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Start of enrollment: 2012 Dec 17
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsLong-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.Theresa Medina, Jason A Chesney, Harriet M Kluger, Omid Hamid, Eric D Whitman
Journal of Clinical Oncology. 2025-11-20 - 2 citationsLifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhib...Harriet Kluger, Götz Ulrich Grigoleit, Sajeve Thomas, Evidio Domingo-Musibay, Jason A Chesney
Cancer Communications. 2025-10-01 - A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carc...Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z Win
Cancer Communications. 2025-08-01
Press Mentions
Cancer Specialists in Florida See Dramatic Results with New Clinical TrialNovember 22nd, 2021
Iovance: Assessing the Potential for Further UpsideMay 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
